The global multiplex assays market size is accounted at USD 2.00 billion in 2025 and is forecasted to hit around USD 6.75 billion by 2034, representing a CAGR of 14.52% from 2025 to 2034. The North America market size was estimated at USD 660 million in 2024 and is expanding at a CAGR of 14.56% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Multiplex Assays Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Multiplex Assays Market Revenue and Volume, by Product
8.1.1. Consumables
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Instruments
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Software
8.1.3.1. Market Revenue and Volume Forecast
9.1. Multiplex Assays Market Revenue and Volume, by Type
9.1.1. Protein Multiplex Assays
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Nucleic Acid Multiplex Assays
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Cell-based Multiplex Assays
9.1.3.1. Market Revenue and Volume Forecast
10.1. Multiplex Assays Market Revenue and Volume, by Technology
10.1.1. Flow Cytometry
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Flow Cytometry
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Luminescence
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Multiplex Real-Time PCR
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Other Technologies
10.1.5.1. Market Revenue and Volume Forecast
11.1. Multiplex Assays Market Revenue and Volume, by End-use
11.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Hospitals & Diagnostic Laboratories
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Research & Academic Institutes
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Other End-users
11.1.4.1. Market Revenue and Volume Forecast
12.1. Multiplex Assays Market Revenue and Volume, by Application
12.1.1. Research & Development
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Clinical Diagnostics
12.1.2.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product
13.1.2. Market Revenue and Volume Forecast, by Type
13.1.3. Market Revenue and Volume Forecast, by Technology
13.1.4. Market Revenue and Volume Forecast, by End-use
13.1.5. Market Revenue and Volume Forecast, by Application
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product
13.1.6.2. Market Revenue and Volume Forecast, by Type
13.1.6.3. Market Revenue and Volume Forecast, by Technology
13.1.6.4. Market Revenue and Volume Forecast, by End-use
13.1.6.5. Market Revenue and Volume Forecast, by Application
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product
13.1.7.2. Market Revenue and Volume Forecast, by Type
13.1.7.3. Market Revenue and Volume Forecast, by Technology
13.1.7.4. Market Revenue and Volume Forecast, by End-use
13.1.7.5. Market Revenue and Volume Forecast, by Application
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product
13.2.2. Market Revenue and Volume Forecast, by Type
13.2.3. Market Revenue and Volume Forecast, by Technology
13.2.4. Market Revenue and Volume Forecast, by End-use
13.2.5. Market Revenue and Volume Forecast, by Application
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product
13.2.6.2. Market Revenue and Volume Forecast, by Type
13.2.6.3. Market Revenue and Volume Forecast, by Technology
13.2.7. Market Revenue and Volume Forecast, by End-use
13.2.8. Market Revenue and Volume Forecast, by Application
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product
13.2.9.2. Market Revenue and Volume Forecast, by Type
13.2.9.3. Market Revenue and Volume Forecast, by Technology
13.2.10. Market Revenue and Volume Forecast, by End-use
13.2.11. Market Revenue and Volume Forecast, by Application
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product
13.2.12.2. Market Revenue and Volume Forecast, by Type
13.2.12.3. Market Revenue and Volume Forecast, by Technology
13.2.12.4. Market Revenue and Volume Forecast, by End-use
13.2.13. Market Revenue and Volume Forecast, by Application
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product
13.2.14.2. Market Revenue and Volume Forecast, by Type
13.2.14.3. Market Revenue and Volume Forecast, by Technology
13.2.14.4. Market Revenue and Volume Forecast, by End-use
13.2.15. Market Revenue and Volume Forecast, by Application
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product
13.3.2. Market Revenue and Volume Forecast, by Type
13.3.3. Market Revenue and Volume Forecast, by Technology
13.3.4. Market Revenue and Volume Forecast, by End-use
13.3.5. Market Revenue and Volume Forecast, by Application
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product
13.3.6.2. Market Revenue and Volume Forecast, by Type
13.3.6.3. Market Revenue and Volume Forecast, by Technology
13.3.6.4. Market Revenue and Volume Forecast, by End-use
13.3.7. Market Revenue and Volume Forecast, by Application
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product
13.3.8.2. Market Revenue and Volume Forecast, by Type
13.3.8.3. Market Revenue and Volume Forecast, by Technology
13.3.8.4. Market Revenue and Volume Forecast, by End-use
13.3.9. Market Revenue and Volume Forecast, by Application
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product
13.3.10.2. Market Revenue and Volume Forecast, by Type
13.3.10.3. Market Revenue and Volume Forecast, by Technology
13.3.10.4. Market Revenue and Volume Forecast, by End-use
13.3.10.5. Market Revenue and Volume Forecast, by Application
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product
13.3.11.2. Market Revenue and Volume Forecast, by Type
13.3.11.3. Market Revenue and Volume Forecast, by Technology
13.3.11.4. Market Revenue and Volume Forecast, by End-use
13.3.11.5. Market Revenue and Volume Forecast, by Application
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product
13.4.2. Market Revenue and Volume Forecast, by Type
13.4.3. Market Revenue and Volume Forecast, by Technology
13.4.4. Market Revenue and Volume Forecast, by End-use
13.4.5. Market Revenue and Volume Forecast, by Application
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product
13.4.6.2. Market Revenue and Volume Forecast, by Type
13.4.6.3. Market Revenue and Volume Forecast, by Technology
13.4.6.4. Market Revenue and Volume Forecast, by End-use
13.4.7. Market Revenue and Volume Forecast, by Application
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product
13.4.8.2. Market Revenue and Volume Forecast, by Type
13.4.8.3. Market Revenue and Volume Forecast, by Technology
13.4.8.4. Market Revenue and Volume Forecast, by End-use
13.4.9. Market Revenue and Volume Forecast, by Application
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product
13.4.10.2. Market Revenue and Volume Forecast, by Type
13.4.10.3. Market Revenue and Volume Forecast, by Technology
13.4.10.4. Market Revenue and Volume Forecast, by End-use
13.4.10.5. Market Revenue and Volume Forecast, by Application
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product
13.4.11.2. Market Revenue and Volume Forecast, by Type
13.4.11.3. Market Revenue and Volume Forecast, by Technology
13.4.11.4. Market Revenue and Volume Forecast, by End-use
13.4.11.5. Market Revenue and Volume Forecast, by Application
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product
13.5.2. Market Revenue and Volume Forecast, by Type
13.5.3. Market Revenue and Volume Forecast, by Technology
13.5.4. Market Revenue and Volume Forecast, by End-use
13.5.5. Market Revenue and Volume Forecast, by Application
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product
13.5.6.2. Market Revenue and Volume Forecast, by Type
13.5.6.3. Market Revenue and Volume Forecast, by Technology
13.5.6.4. Market Revenue and Volume Forecast, by End-use
13.5.7. Market Revenue and Volume Forecast, by Application
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product
13.5.8.2. Market Revenue and Volume Forecast, by Type
13.5.8.3. Market Revenue and Volume Forecast, by Technology
13.5.8.4. Market Revenue and Volume Forecast, by End-use
13.5.8.5. Market Revenue and Volume Forecast, by Application
14.1. R&D Systems, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Advanced Cell Diagnostics
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Perkin Elmer Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Thermo Fischer Scientific
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. QIAGEN N.V
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Promega Connections
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Assay Genie
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Merck KGaA
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Seegene Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Abcam Plc
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample